Skip to main content

A POSITIVE IMPACT.
ON HEALTHCARE.
AND ON LIVES.

Corporate Responsibility

A Message from the Purdue Pharma (Canada) Leadership Team

While prescription opioid medicines remain a safe and effective treatment for patients who are appropriately selected and monitored, like all medicines, prescription opioid medicines have risks, including addiction. Unfortunately, misuse and abuse and diversion of pain medications can lead to tragic consequences, including addiction, overdose and death.

At the same time, according to the Canadian Pain Society, pain is the most common reason for seeking healthcare in Canada. Patients who suffer from chronic pain cannot be ignored.

This complex public health issue is a matter of deep concern to Purdue Pharma (Canada). All stakeholders, including the pharmaceutical industry, have a role to play in providing practical and sustainable solutions.

Purdue Pharma (Canada) supports a research-driven approach to managing pain that may or may not include available prescription products, in combination with other effective pharmacological and non-pharmacological treatments and plans to continue our activities which include:

  • – Providing information and tools to healthcare professionals through our field teams. Examples include: the Patient Agreement & Opioid Risk Tool and The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain issued by the Michael G. DeGroote National Pain Centre at McMaster University, funded by Health Canada and the Canadian Institutes of Health Research; and,
  • – Supporting accredited third-party approved education programs on topics such as Approaches to Responsible Opioid Prescribing, The 2017 Canadian Opioid Guidelines, Non-Pharma Treatment Options and Risk Mitigation Strategies.

In June 2017, Purdue Pharma (Canada) and nine other members of Innovative Medicines Canada voluntarily published aggregated sums of their payments (including services such as speaking) to Canadian healthcare professionals (HCPs) and Healthcare Organizations (HCOs).

This was a first step. Bringing greater transparency to these valuable and well-regulated relationships we hope to increase understanding of the research-based pharmaceutical industry’s collaboration across the healthcare sector, and contribute to enhancing trust and value for patients, as well as our healthcare system.

All transfers of value by Purdue Pharma (Canada) are in compliance with the IMC Code of Ethical Practices.

Purdue Pharma (Canada) has always marketed its products in line with the Health Canada approved product monograph and in compliance with all relevant rules, regulations and codes, including the Food and Drugs Act and the Pharmaceutical Advertising Advisory Board (PAAB) Code.

About Purdue Pharma (Canada)
Purdue Pharma (Canada) is a research-based pharmaceutical and consumer healthcare company which has operated in Canada for over 60 years. Its 400 employees are committed to improving the health and quality of life of Canadians. The company has a broad portfolio of prescription and non-prescription medications including: prescription treatments for pain, attention deficit hyperactivity disorder (ADHD), chemotherapy-induced nausea and vomiting (CINV), various ophthalmic conditions and Consumer Healthcare products. The company supports evidence-based education for the safe use of its products. Its headquarters, located in Pickering, ON, includes integrated research & development, formulation and manufacturing operations. The company is a member of Innovative Medicines Canada and complies with the association’s Code of Ethical Practices. Purdue Pharma (Canada) is part of an independently associated network of companies and is operated independently from Purdue Pharma L.P. in the United States.

Latest News

Doing the right thing

Purdue Pharma (Canada) believes that our corporate responsibility does not stop with providing innovative medicines designed to improve patient health and well-being. We believe we have a larger role to play in the health of our communities and we’re proud of our long standing commitment to corporate citizenship and community service. As part of our corporate responsibility program, we have four areas of focus:

  • Sponsorships, donations and grants

    Purdue Pharma (Canada) takes an active role in supporting organizations that try to improve the quality of life where our employees live and work. We provide sponsorships, donations, in-kind service support and grants.

    Our Commitment to the Community

    Purdue Pharma (Canada) believes its responsibility goes beyond the provision of innovative medicines.  Each year we contribute funding to a wide range of community organizations across Canada. These include health and science education programs, disease awareness initiatives, community agencies as well as the scientific and academic communities.

    As a proud and active member of Canada’s INNOVATIVE MEDICINES CANADA, Purdue Pharma (Canada) supports the Guidelines for Transparency in Stakeholder Funding. Please click here for a list of groups to which the company has provided funding.

    PRODUCT DONATIONS

    Purdue Pharma (Canada) is proud to donate products for international humanitarian aid through Health Partners International of Canada (HPIC).  This agency arranges shipments of products to needed areas of the world and also supplies physician travel packs, containing medicines and medical supplies suitable for use by individual physicians on overseas aid missions.

    If you are a physician interested in product donations to support international medical missions, please contact HPIC directly at 1-800-627-1787 or http://www.hpicanada.ca/.

  • DISCLOSING PAYMENTS TO HCPs AND HCOs

    As an active member of Innovative Medicines Canada, Purdue Pharma (Canada) joins other member companies in voluntarily publishing aggregated sums of payments made to Canadian Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs) to increase transparency about our operations in Canada. Innovative Medicines Canada built a reporting framework to ensure consistency in the approach. As a key stakeholder within the Canadian healthcare system, the pharmaceutical industry plays an important role with patients, caregivers, healthcare practitioners (HCPs), governments, as well as payers in Canada.

    By bringing greater transparency to these valuable and well-regulated relationships we hope to increase understanding of the research-based pharmaceutical industry’s collaboration across the healthcare sector, and contribute to enhancing trust and value for patients, as well as our healthcare system.

    Collaboration among HCPs, HCOs and the pharmaceutical industry is essential to improving the quality of life of Canadians as it drives scientific advancements, enhances medical education, and promotes health literacy.

    View Purdue Pharma (Canada)’s disclosure of 2016 payments.

  • Preventing the diversion and abuse of prescription drugs

    The appropriate management of pain and addressing the effects of misuse, abuse and diversion of prescription pain medications are both serious public health problems. Pain affects millions of people each year. Pain medications remain a safe and effective treatment for appropriately selected and monitored patients. Unfortunately, misuse and abuse and diversion of pain medications can lead to tragic consequences, including addiction, overdose and death. Purdue Pharma (Canada) has been committed to providing resources to support the responsible use of prescription opioids for pain.

    As a pharmaceutical leader in pain medicine, we are acutely aware of the public health risk these powerful medications create, especially when they are diverted, misused and/or abused. That’s why we work with health experts and government agencies on efforts to reduce the risk of opioid abuse and misuse without reducing appropriate pain treatment. At Purdue Pharma (Canada) we support a number of initiatives that address the misuse, abuse and diversion of prescription drugs.

    Learn more

  • Safe disposal of prescription medicine

    Purdue has been an industry advocate of proper storage and safe disposal of prescription medicine. Safe disposal keeps drugs out of the hands of children and other people who might use them inappropriately. It keeps drugs out of landfill sites and water supplies. And it prevents the inadvertent use of unused or expired medications. A proud member of Canada Health Products Stewardship Association (CHPSA), Purdue helps to fund nation-wide programs that ensure safe and effective collection and disposal of prescription medications. Please visit www.healthsteward.ca for more information.

    hpsa

    Don’t throw it out, visit www.healthsteward.ca

  • Employee initiatives

    Purdue Pharma (Canada) employees can expect a work environment that focuses on their health and wellness, while providing opportunities to grow, learn, be engaged and fulfilled.Employees also have the opportunity to give back through volunteer efforts in the community and various fundraising campaigns, such as United Way.

    Each year Purdue Pharma (Canada) employees join together to donate their time, energy and financial resources during our annual employee fundraising campaign for the United Way of Ajax-Pickering-Uxbridge.  Our longstanding commitment to United Way has been recognized year after year with several awards.  In 2009, Purdue Pharma (Canada) celebrated an outstanding campaign with two awards, including a corporate and employee award of excellence honouring the generosity of our company and employees and an award recognizing our employee campaign coordinator for running a successful campaign.

    We also run annual campaigns where employees donate clothes, personal care and household items to Durham-area shelters to help those in need.

    These initiatives help foster a culture of volunteerism where employees have the opportunity to get involved and make a difference.

    For more information on our Corporate Responsibility initiatives, contact us at 905-420-6400.

↓